Please assess the completion status of the following clinical trial:

Trial Title: Stem Cell Transplantation for Fanconi Anemia

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients must be less than (\<) 18 years of age with a diagnosis of Fanconi anemia.~* Patients must have an HLA-A, B, DRB1 identical unrelated donor or less than or equal to (≤)1 antigen mismatched related (non-HLA-matched sibling) or \<1 antigen mismatched unrelated UCB donor. Patients and donors will be typed for HLA-A and B using serological or molecular techniques and for DRB1 using high resolution molecular typing.~* Patients with FA must have aplastic anemia (AA), myelodysplastic syndrome without excess blasts, or high risk genotype as defined below.~  * Aplastic anemia is defined as having at least one of the following when not receiving growth factors or transfusions~ * Platelet count \<20 x 10\^9/L~ * ANC \<5 x 10\^8/L~ * Hgb \<8 g/dL~ * Myelodysplastic syndrome with multilineage dysplasia with or without chromosomal anomalies~ * High risk genotype (e.g. IVS-4 or exon 14 FANCC mutations, or BRCA1 or 2 mutations)~* Adequate major organ function including~  * Cardiac: ejection fraction greater than (\>)45%~ * Hepatic: bilirubin, AST/ALT, ALP \<2 x normal~ * Karnofsky performance status \>70% or Lansky performance status \>50%~* Women of child-bearing age must be using adequate birth control and have a negative pregnancy test~Exclusion Criteria:~* Available HLA-genotypically identical related donor~* History of gram negative sepsis or systemic fungal infection (proven or suspected based on radiographic studies)~* Refractory anemia with excess blasts, or leukemia~* Active central nervous system (CNS) leukemia at time of hematopoietic cell transplant (HCT)~* History of squamous cell carcinoma of the head/neck/cervix within 2 years of HCT~* Pregnant or lactating female~* Prior radiation therapy preventing use of total body irradiation (TBI) 450 centigray (cGy)

- Gender: ALL
- Minimum Age: 1 Day
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- HSCT Patients (Type: EXPERIMENTAL): Patients who received total body irradiation (450 cGy \[centigray\]) with thymic shielding prior to chemotherapy regimen and Hematopoietic Stem Cell Transplant (HSCT)

Based on this trial design, predict the completion outcome and termination type (if applicable).